Michael C. J. Quinn, Karen McCue, Wei Shi, Sharon E. Johnatty, Jonathan Beesley, Andrew Civitarese, Tracy A. O’Mara, Dylan M. Glubb, Jonathan P. Tyrer, Sebastian M. Armasu, Jue Sheng Ong, Puya Gharahkhani, Yi Lu, Bo Gao, Ann-Marie Patch, Peter A. Fasching, Matthias W. Beckmann, Diether Lambrechts, Ignace Vergote, Digna R. Velez Edwards, Alicia Beeghly-Fadiel, Javier Benitez, Maria J. Garcia, Marc T. Goodman, Thilo Dörk, Matthias Dürst, Francesmary Modugno, Kirsten Moysich, Andreas du Bois, Jacobus Pfisterer, Klaus Baumann, AGO Study Group, Beth Y Karlan, Jenny Lester, Julie M. Cunningham, Melissa C. Larson, Bryan M. McCauley, Susanne K. Kjær, Allan Jensen, Claus K. Hogdall, Estrid Hogdall, Joellen M. Schildkraut, Marjorie J. Riggan, Andrew Berchuck, Daniel W. Cramer, Kathryn L. Terry, Line Bjorge, Penelope M. Webb, OPAL Study Group, Michael Friedlander, Tanja Pejovic, Melissa Moffitt, Rosalind Glasspool, Taymaa May, Gabrielle E.V. Ene, David G. Huntsman, Michelle Woo, Michael E. Carney, Samantha Hinsley, Florian Heitz, Sian Fereday, Catherine J Kennedy, Stacey L. Edwards, Stacey J. Winham, Anna deFazio, Australian Ovarian Cancer Study Group, Paul D.P. Pharoah, Ellen L. Goode, Stuart MacGregor, Georgia Chenevix-Trench
Cancer Epidemiol Biomarkers Prev.
Author manuscript; available in PMC 2022 Mar 1.Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Sep; 30(9): 1669–1680. Published online 2021 Jun 23. doi: 10.1158/1055-9965.EPI-20-1817